<DOC>
	<DOC>NCT00163514</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.</brief_summary>
	<brief_title>Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main General good health, other than perennial allergic rhinitis History and diagnosis of perennial allergic rhinitis by skin prick test Parent/caregiver must be capable of understanding the requirements, risks, and benefits of study participation, and, as judged by the investigator, capable of giving informed consent and comply with all study requirements (visits, recordkeeping, etc.) Main Participation in any investigational drug trial within the 30 days preceding the Screening Visit or at any time during the trial Use of any prohibited concomitant medications as defined by the study protocol Nonvaccinated exposure to, or active infection with, chickenpox or measles within the 21 days preceding the Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Perennial Allergic Rhinitis</keyword>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Hay Fever</keyword>
</DOC>